These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 13659100)

  • 41. [On cerebrospinal fluid complement in variou neuropsychiatric diseases].
    Krasil'nikova MN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1652-7. PubMed ID: 6001054
    [No Abstract]   [Full Text] [Related]  

  • 42. [Behavior of cerebrospinal fluid transaminase and dehydrogenase activity in patients with cerebral neoplasms].
    FILIPAZZI A; MARINUCCI M
    Riv Patol Clin; 1961 Dec; 16():837-44. PubMed ID: 13892863
    [No Abstract]   [Full Text] [Related]  

  • 43. [GOT and LDH activity of the cerebrospinal fluid in inflammatory diseases of the nervous system].
    CORRIDORI F; CREMONA T
    Riv Sper Freniatr Med Leg Alien Ment; 1961 Mar; 85():153-60. PubMed ID: 13881466
    [No Abstract]   [Full Text] [Related]  

  • 44. Preliminary evaluation of hydroxylase cofactor in human spinal fluid: potential biochemical and clinical relevance for psychiatric disorders.
    van Kammen DP; Levine R; Sternberg D
    Psychopharmacol Bull; 1978 Oct; 14(4):51-2. PubMed ID: 704761
    [No Abstract]   [Full Text] [Related]  

  • 45. Glutamic-oxalacetic transaminase (GOT) in cerebrospinal fluid in patients with cerebral atrophy.
    Jensen K; Osterman E
    Acta Psychiatr Scand; 1961; 36(2):337-46. PubMed ID: 13789909
    [No Abstract]   [Full Text] [Related]  

  • 46. Glutamic oxalacetic transaminase in the cerebrospinal fluid of man.
    SEVELA M
    Experientia; 1957 Jul; 13(7):295-6. PubMed ID: 13461862
    [No Abstract]   [Full Text] [Related]  

  • 47. Glutamic oxalacetic transaminase in cerebrospinal fluid.
    MIYAZAKI M
    J Nerv Ment Dis; 1958 Feb; 126(2):169-75. PubMed ID: 13525966
    [No Abstract]   [Full Text] [Related]  

  • 48. Glutamic-oxalacetic transaminase activity in spinal fluid.
    KATZMAN R; FISHMAN RA; GOLDENSOHN ES
    Neurology; 1957 Dec; 7(12):853-5. PubMed ID: 13483849
    [No Abstract]   [Full Text] [Related]  

  • 49. [New data on investigation of the cerebrospinal fluid in mental patients].
    MOROZOV VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(3):402-4. PubMed ID: 13457282
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetics of neurological and psychiatric disorders.
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():1-300. PubMed ID: 6823523
    [No Abstract]   [Full Text] [Related]  

  • 51. Performance monitoring in neurological and psychiatric patients.
    Ullsperger M
    Int J Psychophysiol; 2006 Jan; 59(1):59-69. PubMed ID: 16288812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chromatographic studies of the amino acids of the cerebrospinal fluid in mental disorders].
    MAGHERINI G
    Rass Studi Psichiatr; 1954; 43(1):26-32. PubMed ID: 13167478
    [No Abstract]   [Full Text] [Related]  

  • 53. [Transaminase activity in certain nervous system diseases in children].
    FOIS A; CATALANO V; FERRI BM
    Rass Studi Psichiatr; 1958; 47(4):508-12. PubMed ID: 13614708
    [No Abstract]   [Full Text] [Related]  

  • 54. Neurological and psychiatric causes of smell disorders.
    Kumar V; Agell I
    Br J Hosp Med (Lond); 2007 Oct; 68(10):562. PubMed ID: 17974310
    [No Abstract]   [Full Text] [Related]  

  • 55. [Research on neuraminic acid and glucosamine in cerebrospinal fluid of mental patients].
    Scala A
    Rass Neuropsichiatr; 1968; 22(3):379-89. PubMed ID: 5760286
    [No Abstract]   [Full Text] [Related]  

  • 56. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.
    D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P
    Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Limitations of paper electrophoretic determination of blood & CSF proteins in neurological & psychiatric diseases].
    SARTESCHI P; FABIANI P
    Rass Studi Psichiatr; 1956; 45(6):1193-228. PubMed ID: 13420573
    [No Abstract]   [Full Text] [Related]  

  • 58. [Abortion; psychiatric & neurological indications].
    MULLER-HEGEMANN D
    Dtsch Gesundheitsw; 1958 May 8-15; 13(19-20):608-11. PubMed ID: 13547779
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of spinal fluid transaminase determination in the differential diagnosis of low back pain.
    STEVENS JD; HUMOLLER FL; MAJKA FA
    Bull Los Angel Neuro Soc; 1959 Dec; 24():220-3. PubMed ID: 13834538
    [No Abstract]   [Full Text] [Related]  

  • 60. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.
    Arneth B; Birklein F
    Acta Neurol Scand; 2009 Jan; 119(1):39-44. PubMed ID: 18573131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.